文献速递介入腹部外周血管CTDSA

胰胆手术后迟发性出血的急诊血管内治疗:适应症、结局及回顾性队列随访

Emergency endovascular treatments for delayed hemorrhage after pancreaticobiliary surgery: indications, outcomes, and follow-up of a retrospective cohort.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

单中心回顾性分析2010至2017年21例胰胆手术后迟发性出血患者共23次急诊血管内治疗,17/23次CT和22/23次血管造影显示活动性出血,出血多来自肝动脉(43%)、胃十二指肠动脉(22%)和脾动脉(13%);采用弹簧圈、胶、覆膜支架或其组合。结论认为血管内栓塞和/或覆膜支架置入是止血的有效一线干预,可减少急诊再开腹手术需求。

要点

  • 胰胆手术后迟发性出血多源于肝动脉、胃十二指肠动脉和脾动脉,血管造影活动性出血检出率高于CT。
  • 17例为C级术后胰瘘,3例胆漏,1例无胰瘘,提示胰瘘是迟发性出血的重要背景。
  • 血管内治疗以弹簧圈(26%)、胶(22%)、覆膜支架(22%)及组合(30%)为主,再开腹率为19%。

核心结论

  • 采用栓塞和/或覆膜支架置入的血管内治疗是制止胰胆手术后出血的有效一线干预,并减少急诊再开腹手术的需求。

研究设计与样本

  • 单中心回顾性队列研究,纳入21例患者(男:女=13:8,中位年龄64岁),共行23次血管内治疗,时间跨度为2010年至2017年。
  • 16例接受胰十二指肠切除术,3例肝管空肠吻合术,2例远端胰腺切除术。
  • 收集数据包括患者特征、手术、病理、术后胰瘘发生率、CT和血管造影出血征象、受损动脉、所用血管内工具、技术和临床成功、手术至血管内治疗及出院的间隔、生存率。

关键影像表现/征象

  • CT显示活动性出血17/23次,血管造影显示活动性出血22/23次。
  • 出血动脉主要为肝动脉(43%)、胃十二指肠动脉(22%)和脾动脉(13%)。
  • 17例为C级术后胰瘘,3例胆漏,1例无术后胰瘘。

临床应用与阅片要点

  • 对于胰胆手术后迟发性出血,血管内治疗可作为一线干预以止血并降低急诊再开腹手术需求。
  • 血管造影对活动性出血的检出率(22/23)高于CT(17/23),阅片时需注意两者差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the outcomes of emergency endovascular treatments for delayed bleeding after pancreaticobiliary surgery.

METHODS: We retrospectively evaluated 21 patients (M:F = 13:8, median age = 64 years) undergoing 23 endovascular treatments, performed from 2010 to 2017 in a single center. Data collected were patient characteristics; surgery; pathology; incidence of postoperative pancreatic fistulas (POPF); bleeding signs on CT and angiography; damaged artery; endovascular tools used; technical and clinical success; intervals between surgery, endovascular treatment, and discharge; survival rates.

RESULTS: Sixteen patients had pancreatoduodenectomy, three hepaticojejunostomy, two distal pancreatectomy. Indications for surgery were mainly biliary (33%), pancreatic (19%), or duodenal (10%) malignancies. Seventeen patients had "grade C" POPF, three suffered a biliary leak, one had no POPF. Active bleeding was present in 17/23 CTs and in 22/23 angiographies, mostly from hepatic (43%), gastroduodenal (22%), and splenic (13%) arteries. The endovascular treatments were performed with coils (26%), glue (22%), stent-graft (22%), and their combinations (30%). Sixteen patients had a single endovascular treatment, one underwent a second embolization, three had subsequent surgery, one had repeat embolization followed by surgery. Relaparotomy rate was 19%. Median hospital stay was 37 days (range 12-75); median intervals among pancreaticobiliary surgery, endovascular treatment, and discharge were 21 (2-36) and 12 (8-47) days, respectively. We observed 4/21 intrahospital deaths (median: 31 days from endovascular treatment, 4-53); 1-year survival rate of discharged patients was 71%.

CONCLUSIONS: Endovascular treatment using embolization and/or stent-graft placement is a useful first-line intervention to halt postoperative hemorrhage after pancreaticobiliary surgery and decreases the need for urgent relaparotomy.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Muglia R, Lanza E, Poretti D, et al. Emergency endovascular treatments for delayed hemorrhage after pancreaticobiliary surgery: indications, outcomes, and follow-up of a retrospective cohort. Abdom Radiol (NY). 2020. PMID: 32172410. doi:10.1007/s00261-020-02480-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。